High-titer MSCV-based retrovirus generated in the pCL acute virus packaging system confers sustained gene expression in vivo

Journal of Virological Methods

Volumn 75, Issue 2, 1998, Pages 161-167

  Norris, Paula S ^a   Jepsen, Kristen ^a   Haas, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Green fluorescent protein; In vivo expression; MSCV; Retrovirus; Tumor suppressor genes

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TRANSFER; GLIOMA CELL; MOLONEY MURINE SARCOMA ONCOVIRUS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; RETROVIRUS; TUMOR GROWTH; VIRUS TITRATION;

ANIMALS; CELL LINE; CLONING, MOLECULAR; CYTOMEGALOVIRUS; FEMALE; GENES, TUMOR SUPPRESSOR; GENES, VIRAL; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MOLONEY MURINE LEUKEMIA VIRUS; RATS; RECOMBINANT PROTEINS; RETROVIRIDAE;

EID: 0031726347     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00108-6     Document Type: Article

References (25)

1. Bowtell D.D.L., Cory S., Johnson G.R., Gonda T.J. Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J. Virol. 62(7):1988;2464-2473.
2. Challita P.-M., Kohn D.B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;2567-2571.
3. Challita P.-M., Skelton D., El-Khoueiry A., Yu X.-J., Weinberg K., Kohn D.B. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69(2):1995;748-755.
4. WAF1, pRB and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines. Exp. Cell Biol. 238:1998;51-62.
5. Fink, D., Nebel, S., Norris, P.S., Baergen, R.N., Wilczynski, S.P., Costa, M.J., Haas, M., Cannistra, S.A. and Howell, S.B., 1998. Enrichment for DNA mismatch repair-deficient cells during treatment with ciplantin. Int. J. Cancer (in press).
6. Fink D., Zheng H., Nebel S. et al. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res. 57(10):1997;1841-1845.
7. Flanagan J.R., Becker K.G., Ennist D.L. et al. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol. Cell. Biol. 12(1):1992;38-44.
8. Ghazizadeh S., Carroll J.M., Taichman L.B. Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy. J. Virol. 71(12):1997;9163-9169.
9. Grez M., Akgun E., Hilberg F., Ostertag W. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 87:1990;9202-9206.
10. Grez M., Zornig M., Nowock J., Ziegler M. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells. J. Virol. 65:1991;4691-4698.
11. Hawley R.G., Fong A.Z.C., Burns B.F., Hawley T.S. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J. Exp. Med. 176:1992;1149-1163.
12. Hawley R.G., Hawley T.S., Fong A.Z.C. et al. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11. Proc. Natl. Acad. Sci. USA. 93:1996;10297-10302.
13. Hoeben R.C., Migchielsen A.A.J., Jagt R.C.M.v.d., Ormondt H.v., Eb A.J.v.d. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J. Virol. 65(2):1991;904-912.
14. Kay M.A., Li Q., Liu T.-J. et al. Hepatic gene therapy: persistent expression of human α1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3:1992;641-647.
15. Laimins L.A., Gruss P., Pozzatti T., Khoury G. Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus. J. Virol. 49:1984;183-189.
16. McCune S.L., Townes T.M. Retroviral vector sequences inhibit human β-globin gene expression in transgenic mice. Nucleic Acids Res. 22(21):1994;4477-4481.
17. Miller A.D., Rosman G.J. Improved retroviral vectors for gene transfer and expression. BioTechniques. 7(9):1989;980-990.
18. Naviaux R.K., Costanzi E., Haas M., Verma I. The pCL vector system: rapid production of helper-free, high-titer recombinant retroviruses. J. Virol. 70(8):1996;5701-5705.
19. Nelson M.J., Conley F.K., Fajardo L.F. Application of the disk angiogenesis system to tumor-induced neovascularization. Exp. Mol. Pathol. 58:1993;105-113.
20. Norris P.S., Haas M. A fluorescent p53GFP fusion protein facilitates its detection in mammalian cells while retaining the properties of wild-type p53. Oncogene. 15(18):1997;2241-2247.
21. Palmer T.D., Rosman G.J., Osborne W.R.A., Miller A.D. Genetically modified skin fibroblasts persistent long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA. 88:1991;1330-1334.
22. Persons D.A., Allay J.A., Allay E.R. et al. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood. 90(5):1997;1777-1786.
23. Prince V.E., Rigby P.W.J. Derivatives of Moloney murine sarcoma virus capable of being transcribed in embryonal carcinoma stem cells have gained a functional Sp1 binding site. J. Virol. 65:1991;1803-1811.
24. Rettinger S.D., Kennedy S.C., Wu X. et al. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA. 91:1994;1460-1464.
25. Scharfmann R., Axelrod J.H., Verma I.M. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA. 88:1991;4626-4630.